1 Introduction

1 Introduction

This resource has been developed to provide practical information and advice on NICE medical technologies guidance on UrgoStart for treating diabetic foot ulcers and leg ulcers.

NICE's adoption team worked with contributors who use UrgoStart in NHS organisations to gather learning and experiences.

The information presented in this resource is intended solely to support the NHS in using, further researching or evaluating the use of this technology. It is complementary to the guidance and was not considered by the committee when developing its recommendations.

UrgoStart is described in the guidance. The benefits of using UrgoStart as reported by the NHS staff involved in producing this resource include:

  • improving patient outcomes in terms of wound healing and quality of life

  • ease of use

  • long-term cost savings.


This page was last updated: 12 March 2019